ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 83565 | ISO 21474-3:2024 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 3: Interpretation and reports | Standarts spēkā |
| 78110 | ISO 20184-3:2021 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 3: Isolated DNA | Standarts spēkā |
| 79377 | ISO 20776-2:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution | Standarts spēkā |
| 69800 | ISO 20186-3:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 3: Isolated circulating cell free DNA from plasma | Standarts spēkā |
| 67022 | ISO 17822:2020 | In vitro diagnostic test systems — Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens — Laboratory quality practice guide | Standarts spēkā |
| 76677 | ISO 15189:2022 | Medical laboratories — Requirements for quality and competence | Standarts spēkā |
| 59944 | ISO/TS 17518:2015 | Medical laboratories — Reagents for staining biological material — Guidance for users | Standarts spēkā |
| 69445 | ISO/TS 20914:2019 | Medical laboratories — Practical guidance for the estimation of measurement uncertainty | Standarts spēkā |
| 78024 | ISO 21474-2:2022 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification | Standarts spēkā |
| 84816 | ISO/TS 16766:2024 | Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency | Standarts spēkā |
Displaying 111-120 of 142 results.